(19)
(11) EP 3 346 912 A1

(12)

(43) Date of publication:
18.07.2018 Bulletin 2018/29

(21) Application number: 16845218.3

(22) Date of filing: 09.09.2016
(51) International Patent Classification (IPC): 
A61B 5/00(2006.01)
G06F 19/00(2018.01)
G06F 19/22(2011.01)
 C12Q 1/68(2018.01)
G06F 19/12(2011.01)
G06F 19/28(2011.01)
(86) International application number:
PCT/US2016/051155
(87) International publication number:
WO 2017/044885 (16.03.2017 Gazette 2017/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 09.09.2015 US 201562216016 P
09.09.2015 US 201562216028 P
09.09.2015 US 201562215939 P
09.09.2015 US 201562216035 P
09.09.2015 US 201562216042 P

(71) Applicant: Ubiome Inc.
San Francisco, CA 94103 (US)

(72) Inventors:
  • APTE, Zachary
    San Francisco, CA 94103 (US)
  • RICHMAN, Jessica
    San Francisco, CA 94103 (US)
  • ALMONACID, Daniel
    San Francisco, CA 94103 (US)
  • BEHBAHANI, Siavosh, Rezvan
    San Francisco, CA 94103 (US)

(74) Representative: Algemeen Octrooi- en Merkenbureau B.V. 
P.O. Box 645
5600 AP Eindhoven
5600 AP Eindhoven (NL)

   


(54) METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH CEREBRO-CRANIOFACIAL HEALTH